Physician

Bhimavarapu Krishnamohan Reddy, M.D.

According to 2025 Medicare claims, Bhimavarapu Reddy, M.D. (NPI: 1346294485) practices interventional pain management (ipm) in the Dayton-Kettering-Beavercreek, OH market, with the plurality of this provider's patient population coming from Montgomery, OH. This provider's primary affiliated billing organization is DAYTON PAIN CENTER LLC (NPI: 1790730638; TIN: 20-0118498) and primary practice location at 45417-3445.

Reddy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 279 traditional Medicare patients, billed 12,700 HCPCS/CPT codes, and received $150,806 in Medicare payments. The top billing code was G0481 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 1,465 prescription claims across 240 beneficiaries totaling $81,870 in drug costs, led by Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl). Open Payments data shows 13 records totaling $249. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $919,702 to $150,806. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $328,537 to $81,870. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	872	42,436	$919,702
2016	1,034	18,850	$872,680
2017	966	15,097	$852,998
2018	822	11,363	$673,356
2019	564	9,563	$471,205
2020	484	10,181	$381,705
2021	390	6,785	$308,907
2022	360	4,271	$263,407
2023	348	4,052	$242,091
2024	279	12,700	$150,806

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	868	6,394	$328,537
2016	667	5,319	$272,212
2017	767	6,742	$304,675
2018	569	3,441	$172,684
2019	268	1,760	$125,624
2020	240	1,797	$124,661
2021	246	1,344	$110,013
2022	301	1,590	$128,773
2023	259	1,296	$86,603
2024	240	1,465	$81,870

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	56	107	$153
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	93	173	$105
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	139	342	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	180	501	$61
80307	Testing for presence of drug, by chemistry analyzers	112	470	$59

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	444	7,031	$31,210
Belbuca	Buprenorphine Hcl	70	1,451	$27,729
Naloxone Hcl	Naloxone Hcl	59	939	$3,607
Buprenorphine	Buprenorphine	11	308	$2,132
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	183	4,663	$2,085

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$249	Collegium Pharmaceutical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bhimavarapu Krishnamohan Reddy, M.D.?

Tedicare shows public-source Medicare data for Bhimavarapu Krishnamohan Reddy, M.D. (NPI 1346294485), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bhimavarapu Krishnamohan Reddy, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Bhimavarapu Krishnamohan Reddy, M.D.?

Bhimavarapu Krishnamohan Reddy, M.D. is linked to DAYTON PAIN CENTER LLC (billing NPI 1790730638) in the available physician profile data.

Does Bhimavarapu Krishnamohan Reddy, M.D. have Open Payments data?

Bhimavarapu Krishnamohan Reddy, M.D. has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.